VTVT
vTv Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$33.35
−0.36%Margins
Gross margin
100.0%
EBITDA margin
-17.3%
EBIT margin
-25.1%
Net margin
-12.9%
FCF margin
-45.5%
-6.0%
Return on equity
-5.4%
Return on assets
-11.8%
Return on invested capital
0.40x
Asset turnover
-$16.8M
Cash from operations
$22
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026